the levels of prostatic specific antigen ( psa ) and prostatic acid phosphatase ( pap ) , both measured by radioimmunoassay , and two cancer indices given by the ratio of serum alpha-1 acid glycoprotein to prealbumin ( agp : palb ) and alpha-1 acid glycoprotein to alpha-2 hs globulin ( agp : hs ) were evaluated as markers to assess the response of prostatic cancer to treatment with zoladex , an lh-rh agonist .
C0032923
prealbumin
C1421224
palb